Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
604.45
10.7 (1.8%)
BSENSE

Sep 23, 04:01 PM

BSE+NSE Vol: 17.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLincoln Pharma. VS Pharmaceuticals & Biotechnology
 
1D
1.8%
0.4%
1W
2.31%
0.66%
1M
-2.08%
-3.5%
YTD
25.09%
-12.19%
1Y
10.19%
-8.86%
3Y
20.56%
13.36%
5Y
54.35%
24.95%
10Y
142.9%
161.01%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.3%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.44%
0.29%
-0.15%
6 Months
3.23%
0.31%
3.54%
1 Year
10.19%
0.34%
10.53%
2 Years
-15.41%
0.54%
-14.87%
3 Years
20.56%
0.71%
21.27%
4 Years
108.43%
1.74%
110.17%
5 Years
54.35%
1.75%
56.1%

Latest dividend: 1.8129068643248467 per share ex-dividend date: Sep-11-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-4.83%
4
Quartile
quartile-4
Mar-Jun
10.55%
1
Quartile
quartile-1
Dec-Mar
16.79%
2
Quartile
quartile-2
YTD
8.24%
4
Quartile
quartile-4
2025
-38.62%
3
Quartile
quartile-3
2024
29.24%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.83%
4
Quartile
quartile-4
Mar-Jun
10.55%
1
Quartile
quartile-1
Dec-Mar
16.79%
2
Quartile
quartile-2
YTD
8.24%
4
Quartile
quartile-4
2025
-38.62%
3
Quartile
quartile-3
2024
29.24%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.83%
4
Quartile
quartile-4
Mar-Jun
10.55%
1
Quartile
quartile-1
Dec-Mar
16.79%
2
Quartile
quartile-2
YTD
8.24%
4
Quartile
quartile-4
2025
-38.62%
2
Quartile
quartile-2
2024
29.24%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
Footer loading